1. Home
  2. IEP vs STVN Comparison

IEP vs STVN Comparison

Compare IEP & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Icahn Enterprises L.P.

IEP

Icahn Enterprises L.P.

HOLD

Current Price

$7.63

Market Cap

4.7B

ML Signal

HOLD

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$14.99

Market Cap

4.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IEP
STVN
Founded
1987
1949
Country
United States
Italy
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Containers/Packaging
Sector
Consumer Discretionary
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
4.2B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
IEP
STVN
Price
$7.63
$14.99
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$25.67
AVG Volume (30 Days)
929.3K
565.5K
Earning Date
05-28-2026
01-01-0001
Dividend Yield
26.35%
0.43%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,658,000,000.00
N/A
Revenue This Year
N/A
$10.26
Revenue Next Year
N/A
$10.02
P/E Ratio
N/A
$27.15
Revenue Growth
N/A
N/A
52 Week Low
$7.08
$13.91
52 Week High
$9.99
$28.00

Technical Indicators

Market Signals
Indicator
IEP
STVN
Relative Strength Index (RSI) 40.14 43.56
Support Level $7.08 $14.03
Resistance Level $8.33 $17.14
Average True Range (ATR) 0.20 0.87
MACD -0.06 0.04
Stochastic Oscillator 15.56 25.11

Price Performance

Historical Comparison
IEP
STVN

About IEP Icahn Enterprises L.P.

Icahn Enterprises LP provides diversified business services in the United States. The company operates its business through varied segments which include Investment, Automotive, Energy, Food Packaging, Real Estate, Pharma, and Home Fashion. Among these, the Energy segment derives the maximum revenue from the company. Geographically, it generates maximum revenue from the United States.

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

Share on Social Networks: